Treating autism with Bumetanide: Identification of responders using Q-Finder machine learning algorithm Bumetanide, a specific NKCC1 co-transporter inhibitor, restores deficient GABAergic inhibition implicated in various brain disorders, including Autism Spectrum Disorders (ASD). In keeping with this mechanism, nine successful phase 2 clinical trials, ...

#asd #bumetanide #ManyAutisms

"... highlighting the limitations of a one-size-fits-all approach for heterogeneous conditions such as ASD"

These limitations probably apply in other areas of medicine as well.

pmc.ncbi.nlm.nih.gov/articles/PMC...